CIK 0001005286
- Accelerated filer
- Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943025618
- Phone
- +1 952-368-4300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −71,574 | $9.35 | $669K | 71,574 |
| 2019-05-23 | GOLDBY STEVEN D Director | Exercise or conversion | +4,240 | 73,137 | ||
| 2019-05-23 | GOLDBY STEVEN D Director | Exercise or conversion · Restricted Stock Unit | −4,240 | 0 | ||
| 2019-05-22 | Hall James G Executive Vice President | Exercise or conversion | +7,000 | $9.66 | $68K | 10,475 |
| 2019-05-22 | Hall James G Executive Vice President | Shares withheld for taxes | −2,207 | $9.66 | $21K | 8,268 |
| 2019-05-22 | Hall James G Executive Vice President | Exercise or conversion · Restricted Stock Unit | −7,000 | 0 | ||
| 2019-04-29 | FRANK FRED Director | Exercise or conversion | +5,000 | $6.66 | $33K | 59,001 |
| 2019-04-29 | FRANK FRED Director | Shares withheld for taxes | −3,217 | $10.35 | $33K | 55,784 |
| 2019-04-29 | FRANK FRED Director | Exercise or conversion · Nonstatutory Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2019-04-10 | OBUS NELSON Director | Purchase | +30,000 | $10.33 | $310K | 2,795,300 |
| 2019-04-09 | OBUS NELSON Director | Purchase | +10,000 | $10.24 | $102K | 2,765,300 |
| 2019-04-08 | OBUS NELSON Director | Purchase | +20,000 | $10.38 | $208K | 2,755,300 |
| 2019-03-12 | Tobin Robert Director | Exercise or conversion | +5,000 | $6.66 | $33K | 56,568 |
| 2019-03-12 | Tobin Robert Director | Shares withheld for taxes | −2,691 | $6.66 | $18K | 53,877 |
| 2019-03-12 | Tobin Robert Director | Exercise or conversion · Nonstatutory Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2019-02-28 | GOLDBY STEVEN D Director | Exercise or conversion | +5,000 | $6.66 | $33K | 71,490 |
| 2019-02-28 | GOLDBY STEVEN D Director | Shares withheld for taxes | −2,593 | $12.84 | $33K | 68,897 |
| 2019-02-28 | GOLDBY STEVEN D Director | Exercise or conversion · Nonstatutory Stock Option (Right to Buy) | −5,000 | 5,000 | ||
| 2019-02-08 | OBUS NELSON Director | Purchase | +5,000 | $12.15 | $61K | 2,735,300 |
| 2019-02-07 | OBUS NELSON Director | Purchase | +7,900 | $12.10 | $96K | 2,730,300 |
Page 22 of 27 · 528 trades